← Back to Search

Behavioural Intervention

Active stimulation for Depression

N/A
Waitlist Available
Research Sponsored by Flow Neuroscience AB
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks

Summary

This trial tests whether the Flow FL-100 tDCS device, which sends small electrical currents to the brain, is effective for people with major depressive disorder. Participants will use the device at home for several sessions over a few months without supervision. The goal is to see if this device can help improve their mood and reduce depression symptoms. Transcranial direct current stimulation (tDCS) has been studied extensively and shown potential efficacy in treating depression.

Eligible Conditions
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HDRS-17

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active stimulationActive Control1 Intervention
Active stimulation at 2mA
Group II: Sham stimulationPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

University of TexasOTHER
189 Previous Clinical Trials
142,965 Total Patients Enrolled
11 Trials studying Depression
1,296 Patients Enrolled for Depression
Flow Neuroscience ABLead Sponsor
University of East LondonOTHER
10 Previous Clinical Trials
645 Total Patients Enrolled
2 Trials studying Depression
51 Patients Enrolled for Depression
~51 spots leftby Oct 2025